Contact us : info@bioworlde.com
Home > Product > Antigen-Peptide
RAB7L1 Peptide BS5879P
Product NameRAB7L1 Peptide
Catalog No.BS5879P
ApplicationsBlocking
Swiss-ProtO14966
Product1 mg/ml in DI water.
Purification&PuritySynthetic peptide RAB7L1. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&StabilityStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
SpecificityThis peptide can be used with studies using BS5879 RAB7L1 pAb.
Browse similar products>>
Size Price
1mg $368
Add to cart My orders
Product Name :
RAB7L1 Peptide
Applications :
Blocking
Background :
The Ras-related superfamily of guanine nucleotide binding proteins includes the R-Ras, Rap, Ral/Rec and Rho/Rab subfamilies. Increasing data suggests an important role for Rab proteins in either endocytosis or in biosynthetic protein transport. The process of transporting newly synthesized proteins from the endoplasmic reticulum (ER) to various stacks of the Golgi complex and to secretory vesicles involves the movement of carrier vesicles and requires Rab protein function. Rab proteins are also an integral part of endocytic pathways. Rab 7L1, also known as RAB7L, is a 203 amino acid, ubiquitously expressed member of the Rab family of proteins that localizes to the cell membrane. Rab 7L1 contains four GTP-binding domains and shares 35% identity with Rab 7 and 94% identity with the rat protein Rab 29. In addition, Rab 7L1 is often used as a marker of T cells.
Alternative Name :
Ras-related protein Rab-7L1; Rab-7-like protein 1; RAB-7L1
Swiss-Prot :
O14966
Product :
1 mg/ml in DI water.
Purification&Purity :
Synthetic peptide RAB7L1. (Note: the amino acid sequence is proprietary). The purity is > 98%.
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
This peptide can be used with studies using BS5879 RAB7L1 pAb.
Blocking peptide available as BS5879PP
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER